In our previous study, our findings also evidenced that, when p53 mutant or deleted, the binding between p53 and miR-124 did not promote the expression of miR-124, and the expression of iASPP showed to be upregulated, eventually leading to enhanced viability of CRC cells in response to PDT treatment (11). The gene discussed is TP53; the disease is colorectal carcinoma.